1-3 of 3
Ron Gartenhaus, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lipid Addiction of Diffuse Large B-Cell Lymphoma (DLBCL): Fatty Acid Synthase (FASN) and PI3K Dependent Cell Death Identifies a Novel Therapeutic Paradigm

Ravi Dashnamoorthy, PhD, Afshin Beheshti, PhD, Nassera Abermil, MS, PharmD, Frederick Lansigan, MD, William Kinlaw, MD, Ron Gartenhaus, MD, Graham Jones, PhD DSc, Lynn Hlatky, PhD, Andrew M. Evens, DO, MSc
Journal: Blood
Blood (2015) 126 (23): 1284.
https://doi.org/10.1182/blood.V126.23.1284.1284
Published: 2015
Journal Articles

Selective MEK Inhibition with AZD-6244 (selumetinib) in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A University of Chicago Phase II Consortium Trial

Natalie Galanina, MD, Sonali M. Smith, MD, Chuanhong Liao, PhD, Adam M. Petrich, MD, Bernadette Libao, Ron Gartenhaus, MD, Jason R Westin, MD, Kenneth S. Cohen, MD, James Knost, MD, Walter Stadler, MD, Austin Doyle, MD, Theodore Karrison, PhD, Leo I. Gordon, MD, Andrew M Evens, DO, MS
Journal: Blood
Blood (2015) 126 (23): 3990.
https://doi.org/10.1182/blood.V126.23.3990.3990
Published: 2015
Journal Articles

The Novel 2 nd Generation Small Molecule MEK Inhibitor, AZD-6244, Induces Cell Death in Lymphoma Cells Lines, Primary Cells, and in a Human Lymphoma Xenograft Model.

Savita Bhalla, PhD, Ron Gartenhaus, MD, Bojie Dai, PhD, Sheila Prachand, Arindam Mukherjee, Rebecca L Elstrom, MD, Leo I. Gordon, MD, Andrew M. Evens, DO, MSc
Journal: Blood
Blood (2009) 114 (22): 285.
https://doi.org/10.1182/blood.V114.22.285.285
Published: 2009